Irving Dark

Shailesh Chavan

Physician-scientist executive with experience in the industry (pharma, biotech & CRO). Leadership role with focus on patient centric innovation, building and leading high performing teams in Early to Late Phase Product development, launch and life-cycle management, business development, due diligence and integration. Ability to integrate development and operations experience in various TA’s including Immunology, Oncology, Neurology and Transplantation.
All opinions and views are my own.

Jennifer Sydney Goldman

I’m a clinical finance and operations leader with 20+ years of experience driving global strategies for clinical trial financial planning, strategic outsourcing, vendor management, site contracts and budgets, and investigator grant payments.

I specialize in optimizing systems and workflows to ensure accuracy, compliance, and audit readiness, while building strong cross-functional partnerships across Clinical Operations, Finance, Legal, and Outsourcing.

My experience is predominantly with early-stage biotech, preparing for Phase 1 trials and IPO in 1-3 years. While hands on, as the portfolio grows, I’ve built and led Clinical Business Operations teams.

I enjoy solving complex problems, mentoring teams, implementing automation tools, and working at the intersection of data, people, and purpose-ultimately enabling faster, more transparent trials that serve patients and sites alike, while ensuring financial control and compliance with regulatory requirements.

Richard A. Graham

Richard Graham, founder of Mirador Therapeutics and TruTechnologies, is a seasoned leader with extensive experience in business operations, corporate strategy, fundraising, scientific research, and therapeutics development. He excels at aligning corporate strategy with scientific expertise and building partnerships with executives, board members, and investors.

A proven leader in global team management, Rick has successfully driven large-scale R&D programs from concept to completion, consistently achieving ambitious milestones. His work has advanced therapeutics through late-stage development, contributing to the approvals of Erivedge™, Kadcyla™, Kyprolis™, Perjeta™, and Yupelri™.

Brad Stefanovic

Clinical Research, Bio-Tech, expert with over 18 years of experience working in the Life Sciences Industry. Brings a unique blend of clinical trial expertise, safety management, scientific and technology consulting. Possesses strong team-working, leadership, communication skills and attention to detail. Enthusiastic and excited about furthering the cause of clinical research.

I was born in Australia and reside in New York City, NY and I am fortunate to be in an extremely active family. Being from this environment with active siblings had thrust me into a leadership position early in my life and I have embraced that leadership mentality ever since. I wake every morning thankful for the great family and friends I now call family.

Lori Lombardo

VP & Therapeutic Area Leader, Dermatology and General Medicine, leads Caidya’s team of dermatology operational, clinical, and medical specialists. With more than 28 years of experience in both pharma and CROs building collaborative partnerships, Lori’s clinical development, project and program management, and insights into a wide range of dermatology indications distinctly position her to help sponsors advance their dermatology programs.